How is this different from Wolverine?

It adds KPV, and it is not an even split — TB-500 is twice BPC-157 rather than equal to it. Wolverine is the two repair peptides alone at 1:1.

Why is the composition marked as single-vendor?

GLOW and KLOW have a split you can check across many sellers. This one we found at one. That does not make it wrong; it means we cannot confirm it is standard, and a different seller's Deadpool may hold something else.

Healing & recovery

Deadpool

Deadpool stack · Deadpool blend

PreclinicalProhibited in sportReviewed 25 Aug 2026

What is in the vial

Components of Deadpool and their share of a standard vial.
Compound	Per vial	Share
TB-500The largest component. Associated with cell migration through actin binding.	10 mg	50%
BPC-157Associated with angiogenesis in animal models.	5 mg	25%
KPVAnti-inflammatory in cell and animal work. What distinguishes this from Wolverine.	5 mg	25%

The ratio is fixed in the vial. Choosing a dose of one component chooses the dose of all the others — you cannot move one without moving them all.

What the contents cost separately

The same masses this vial holds, bought as individual vials, at the cheapest confirmed listing and at the median across vendors. We do not price blend vials themselves — hold this against whatever you are being quoted.

$65–$81

for 20 mg across 3 compounds

Cost of each component bought separately
Compound	In this vial	Separately
TB-500	10 mg	$35–$45
BPC-157	5 mg	$15–$18
KPV	5 mg	$15–$19

Buying separately costs more injections and more vials, and buys back the ability to change one dose without changing the others. Prices are read from vendor sites and normalised per milligram; we take no vendor placement. Every listing.

Deadpool is the repair pair with KPV added, at 2:1:1 rather than the even split Wolverine uses. A 20 mg vial holds 10 mg TB-500 and 5 mg each of BPC-157 and KPV.

It is the least widely sold of the named repair blends. The composition here comes from one vendor's listing; unlike GLOW and KLOW, there is no consensus across sellers to check it against. Treat the split on any vial you are handed as that seller's choice rather than a standard.

Compared with KLOW it has no GHK-Cu, so it is not blue and contributes no copper. Compared with Wolverine it adds KPV and doubles TB-500 relative to BPC-157.

How it works

Three separate mechanisms arriving together, none studied in combination.

TB-500 binds actin and is associated with cell migration.

BPC-157 is associated with angiogenesis in animal models.

KPV is a tripeptide fragment of alpha-MSH with anti-inflammatory activity in cell and animal work.

Quick reference

Commonly described dose: 500 mcg–1 mg
How often: Daily, in courses of 4 to 8 weeks
Route: Subcutaneous
Where: Abdomen, Thigh, Near the injury site
Timing: No timing effect established for the mixture.
Storage once mixed: Refrigerated, 30 days

These describe what sources report, not what you should do. Full detail and provenance in the dosing section below.

Price index

Per-milligram pricing across vendors arrives with the directory. We are recording prices now so the history exists when the page ships.

Vocabulary on this page

Blend: One vial containing several peptides at a fixed ratio, reconstituted and drawn together.
Vial: The small sealed glass container a peptide is sold in, holding a stated mass of freeze-dried powder under a rubber stopper.
Injection site: Where on the body an injection is given. Rotating between sites is standard practice for anything given repeatedly.
Peptide: A short chain of amino acids: the same building blocks as a protein, in a chain short enough to behave differently.

The whole glossary →

Regulatory status — United States

Not approved anywhere as a mixture or as any of its parts. Sold as a research chemical, and documented at fewer vendors than GLOW, KLOW or Wolverine.

Last reviewed 25 Aug 2026. Regulatory positions in this category change frequently; we date this line so you can see how current it is.

What it is studied for

Each entry states the evidence behind it. We do not rank indications by effectiveness — for most compounds here, that would be a claim nobody can support.

Tissue repair with an anti-inflammatory component

Published review

What the combination is sold for.

EvidenceNo study of the mixture exists. Every component is separately supported by animal or cell-culture work only.

Identity and clearance

Molecule

Class: Pre-mixed blend of three peptides, 2:1:1 by mass

A 20 mg vial is 10 mg TB-500 with 5 mg each of BPC-157 and KPV. Single-vendor composition; no cross-seller consensus exists.

Dose protocols reported in sources

Displayed for reference only. Every row says where it came from, and a trial protocol and a community convention are not the same kind of information. None of this is fed into the calculator, and none of it is a recommendation.

Dose protocols reported in sources, with the source of each.
Goal	Dose	Frequency	Route	Units, 20 mg vial	Source	Start this protocol
Commonly described community protocol	500 mcg – 1 mg	Daily, in courses of 4 to 8 weeks	SubcutaneousTotal blend. At 2:1:1, 500 mcg of blend delivers 250 mcg TB-500 with 125 mcg each of BPC-157 and KPV.	12.5–25 u	Community practice	Start this

Start this copies a row into a protocol of your own, which you can then edit. Where a source gave a dose range or an ambiguous frequency, those fields arrive empty — we will not pick a number on your behalf.

CheckRows marked community practice describe what people commonly do, drawn from public discussion. They are not derived from any trial and are not evidence that a dose is safe or effective.

Calculator

Work out what to draw

Pre-filled with a 20 mg vial as a worked example. These are not recommended values — change them to match the vial in front of you.

Draw to 5 units on a 1 mL U-100 syringe. That is 0.05 mL, containing 500 mcg of Deadpool.

Concentration10mg / mL

Volume drawn0.05mL

Doses per vial40doses

Per unit100mcg / unit

Check5 units falls between the printed lines on a 1 mL U-100 syringe. Mixing with 1.6 mL of water instead would put this dose at 4 units.

Get a shareable image Read the profile

Bioalmanac performs arithmetic on values you enter. It does not recommend doses, schedules or compounds, and nothing here is medical advice. Confirm every calculation against your vial and syringe before drawing, and speak with a licensed healthcare provider.

Open this calculation in the full calculator

Units, concentration, bacteriostatic water — the glossary defines the vocabulary, and a unit is not a fixed volume.

Safety

Reported effects

Everything from three compounds at oncePublished review
Unknown
No human study of the mixture. Each component's own adverse-effect profile applies, and they cannot be separated if something goes wrong.
Injection site reactionsCommunity practice
Commonly reported

When to stop

Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
An injection site that becomes hot, spreading or produces pus.
Any new or changing lump. Two components are associated with proliferation in animal models.

Interactions and situations that need care

Active or previous cancerAvoid
Components associated with angiogenesis and proliferation in animal models, none studied in anyone with a malignancy.
Wanting to control the dose of one componentUse caution
Three compounds at a fixed ratio means Three doses chosen at once. Running them separately is the only way to dose them separately.
Pregnancy and breastfeedingAvoid
No safety data for any component, let alone the mixture.
Competing in a tested sportAvoid
Components are WADA S2, prohibited at all times.

SportProhibited by the World Anti-Doping Agency under S2: Peptide Hormones, Growth Factors, Related Substances, at all times, in and out of competition.

What to expect

HonestlyThere is no human efficacy data for this compound, so there is no evidence-based timeline to give. Any site publishing a week-by-week schedule of expected effects has invented it.

No study of the mixture. All three components are animal-evidence only.
The least widely sold of the named repair blends, and the composition rests on a single vendor.
No GHK-Cu, so no copper and no blue colour.
Three fixed doses chosen at once, tilted 2:1:1 toward TB-500.

Storage and handling

Freeze-dried powder: Refrigerated at 2–8 °C, protected from light.
After mixing: Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes every component with it.
Long-term, frozen: Unopened powder is stable at −20 °C or colder.

Printable one-pager How to reconstitute a vial, step by step

With other peptides

Wolverinecaution
Wolverine is two of these three components. Running both means taking BPC-157 and TB-500 twice.
KLOWcaution
KLOW contains all three of these plus GHK-Cu. Running both means taking BPC-157, TB-500 and KPV twice.
Klowverinecaution
Klowverine contains all three of these at higher masses plus GHK-Cu. Running both means taking all three twice.

Check this against a whole stack

Checking your vial

Research chemicals carry no manufacturing standard, so what the vial looks like is often the only quality signal available before you use it. More on assessing quality and COAs.

Clear and colourless after reconstitution
Nothing here is coloured. A tinted solution is not this blend.
Cloudiness or visible particles
Discard it.
Sold by few vendors
With no cross-seller consensus on the split, the ratio is whatever this seller chose. Ask for it in writing.

Questions

How is this different from Wolverine?: It adds KPV, and it is not an even split — TB-500 is twice BPC-157 rather than equal to it. Wolverine is the two repair peptides alone at 1:1.
Why is the composition marked as single-vendor?: GLOW and KLOW have a split you can check across many sellers. This one we found at one. That does not make it wrong; it means we cannot confirm it is standard, and a different seller's Deadpool may hold something else.

References

Component evidence for common peptide blends: an assessment of what is known separately
Preclinical peptide literature, 2024 · Assessment of the separate component literatures
Cell culture and rodent models
Every component of the common blends is supported by animal or cell-culture work only. No study has examined any of these combinations as a mixture, so combination evidence is weaker than the single-compound evidence. That is itself preclinical.
Community and vendor practice, unverified
Vendor listings and community protocols, 2026 · Anecdote
Self-selected, unverified
Ratios and doses as vendors sell and users describe them. Ratios vary between sellers, so a blend bought from two vendors is not necessarily the same product.

Related compounds

Wolverine

BPC-157 and TB-500 in one vial at 1:1. The oldest and simplest of the named blends, and the only one without a settled vial size.

KLOW

GLOW with KPV added: four compounds in one vial at 5:1:1:1. The newest and least studied of the common blends.

Klowverine

KLOW with the three repair peptides doubled: 50 mg GHK-Cu with 20 mg each of BPC-157, TB-500 and KPV. The least documented of the named blends.

BPC-157

A synthetic 15-amino-acid peptide studied in animals for effects on tendon, ligament and gut tissue repair. No completed human trials.

Keep this page honest

If something here is wrong, out of date, or missing a source, tell us and we will fix it and say that we did.

Suggest a correction

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice. No clinician reviews these pages.

Page last updated 25 Aug 2026